FindTrial
Sign In

Genetics in High Blood Sugar Patients

Genetic Study of Transcription Factor 7 Like 2 (TCF7L2) Gene Polymorphism in Type 2 Diabetes Mellitus - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091672
Enrollment
164
Registered
2025-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

BLDE Deemed to be University Shri B M Patil Medical College Hospital and Research Centre
Lead Sponsor
Dr Sankranthi Rajasekhar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients Admitted/ Attending OPD with Type 2 Diabetes Mellitus.

Exclusion criteria

Exclusion criteria: 1. Patients with Type 1 Diabetes Mellitus. 2. Patients with Thyroid Disorders. 3. Patients with Polycystic Ovary Disease. 4. Patients with Gestational Diabetes.

Design outcomes

Primary

MeasureTime frame
TO identify the individual risk of TCF7L2 gene mutation in patients with type 2 diabetes mellitus.Timepoint: 12 months—

Secondary

MeasureTime frame
This study will be helpful for the development of biomarkers for clinicians & the community. By using the study s aggregated data for early detection of type 2 diabetes mellitus & early intervention, the burden of disease in terms of morbidity & mortality of disease will be reduced.Timepoint: 12 month—

Countries

India

Contacts

Public ContactDr. Badiger Sharanabasawappa

BLDE Deemed to be University Shri B M Patil Medical College, Hospital and Research Centre

sharanrb@rediffmail.com9448434927

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026